RISK LOCUS FOR PSORIATIC ARTHRITIS

The present invention provides methods for diagnosing psoriatic arthritis (PsA) in an individual. Specifically, the method relates to detecting the presence or absence of an intergenic deletion between the human ADAMTS9 and MAGI1 genes. Also provided herein are methods for determining whether a subj...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FERRÁNDIZ FORASTER, Carlos, DE DIOS CAÑETE CRESPILLO, Juan, BARRIL, Sara Marsal, CANO, Antonio Julià
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FERRÁNDIZ FORASTER, Carlos
DE DIOS CAÑETE CRESPILLO, Juan
BARRIL, Sara Marsal
CANO, Antonio Julià
description The present invention provides methods for diagnosing psoriatic arthritis (PsA) in an individual. Specifically, the method relates to detecting the presence or absence of an intergenic deletion between the human ADAMTS9 and MAGI1 genes. Also provided herein are methods for determining whether a subject has a risk of developing PsA. The methods described herein can be used for selecting a treatment of a subject suspected of having PsA. La présente invention concerne des procédés de diagnostic du rhumatisme psoriasique (RPs) chez un individu. En particulier, le procédé concerne la détection de la présence ou de l'absence d'une délétion intergénique entre les gènes ADAMTS9 et MAGI1 humains. L'invention concerne également des procédés pour déterminer si un sujet présente un risque de développer le RPs. Les procédés décrits dans la description peuvent être utilisés pour sélectionner un traitement d'un sujet susceptible d'être atteint de RPs.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2016170513A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2016170513A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2016170513A13</originalsourceid><addsrcrecordid>eNrjZFAK8gz2VvDxdw4NVnDzD1IICPYP8nQM8XRWcAwK8QjyDPEM5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGZobmBqaGxo6GxsSpAgDQkyN7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RISK LOCUS FOR PSORIATIC ARTHRITIS</title><source>esp@cenet</source><creator>FERRÁNDIZ FORASTER, Carlos ; DE DIOS CAÑETE CRESPILLO, Juan ; BARRIL, Sara Marsal ; CANO, Antonio Julià</creator><creatorcontrib>FERRÁNDIZ FORASTER, Carlos ; DE DIOS CAÑETE CRESPILLO, Juan ; BARRIL, Sara Marsal ; CANO, Antonio Julià</creatorcontrib><description>The present invention provides methods for diagnosing psoriatic arthritis (PsA) in an individual. Specifically, the method relates to detecting the presence or absence of an intergenic deletion between the human ADAMTS9 and MAGI1 genes. Also provided herein are methods for determining whether a subject has a risk of developing PsA. The methods described herein can be used for selecting a treatment of a subject suspected of having PsA. La présente invention concerne des procédés de diagnostic du rhumatisme psoriasique (RPs) chez un individu. En particulier, le procédé concerne la détection de la présence ou de l'absence d'une délétion intergénique entre les gènes ADAMTS9 et MAGI1 humains. L'invention concerne également des procédés pour déterminer si un sujet présente un risque de développer le RPs. Les procédés décrits dans la description peuvent être utilisés pour sélectionner un traitement d'un sujet susceptible d'être atteint de RPs.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20161027&amp;DB=EPODOC&amp;CC=WO&amp;NR=2016170513A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20161027&amp;DB=EPODOC&amp;CC=WO&amp;NR=2016170513A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FERRÁNDIZ FORASTER, Carlos</creatorcontrib><creatorcontrib>DE DIOS CAÑETE CRESPILLO, Juan</creatorcontrib><creatorcontrib>BARRIL, Sara Marsal</creatorcontrib><creatorcontrib>CANO, Antonio Julià</creatorcontrib><title>RISK LOCUS FOR PSORIATIC ARTHRITIS</title><description>The present invention provides methods for diagnosing psoriatic arthritis (PsA) in an individual. Specifically, the method relates to detecting the presence or absence of an intergenic deletion between the human ADAMTS9 and MAGI1 genes. Also provided herein are methods for determining whether a subject has a risk of developing PsA. The methods described herein can be used for selecting a treatment of a subject suspected of having PsA. La présente invention concerne des procédés de diagnostic du rhumatisme psoriasique (RPs) chez un individu. En particulier, le procédé concerne la détection de la présence ou de l'absence d'une délétion intergénique entre les gènes ADAMTS9 et MAGI1 humains. L'invention concerne également des procédés pour déterminer si un sujet présente un risque de développer le RPs. Les procédés décrits dans la description peuvent être utilisés pour sélectionner un traitement d'un sujet susceptible d'être atteint de RPs.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAK8gz2VvDxdw4NVnDzD1IICPYP8nQM8XRWcAwK8QjyDPEM5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGZobmBqaGxo6GxsSpAgDQkyN7</recordid><startdate>20161027</startdate><enddate>20161027</enddate><creator>FERRÁNDIZ FORASTER, Carlos</creator><creator>DE DIOS CAÑETE CRESPILLO, Juan</creator><creator>BARRIL, Sara Marsal</creator><creator>CANO, Antonio Julià</creator><scope>EVB</scope></search><sort><creationdate>20161027</creationdate><title>RISK LOCUS FOR PSORIATIC ARTHRITIS</title><author>FERRÁNDIZ FORASTER, Carlos ; DE DIOS CAÑETE CRESPILLO, Juan ; BARRIL, Sara Marsal ; CANO, Antonio Julià</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2016170513A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2016</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>FERRÁNDIZ FORASTER, Carlos</creatorcontrib><creatorcontrib>DE DIOS CAÑETE CRESPILLO, Juan</creatorcontrib><creatorcontrib>BARRIL, Sara Marsal</creatorcontrib><creatorcontrib>CANO, Antonio Julià</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FERRÁNDIZ FORASTER, Carlos</au><au>DE DIOS CAÑETE CRESPILLO, Juan</au><au>BARRIL, Sara Marsal</au><au>CANO, Antonio Julià</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RISK LOCUS FOR PSORIATIC ARTHRITIS</title><date>2016-10-27</date><risdate>2016</risdate><abstract>The present invention provides methods for diagnosing psoriatic arthritis (PsA) in an individual. Specifically, the method relates to detecting the presence or absence of an intergenic deletion between the human ADAMTS9 and MAGI1 genes. Also provided herein are methods for determining whether a subject has a risk of developing PsA. The methods described herein can be used for selecting a treatment of a subject suspected of having PsA. La présente invention concerne des procédés de diagnostic du rhumatisme psoriasique (RPs) chez un individu. En particulier, le procédé concerne la détection de la présence ou de l'absence d'une délétion intergénique entre les gènes ADAMTS9 et MAGI1 humains. L'invention concerne également des procédés pour déterminer si un sujet présente un risque de développer le RPs. Les procédés décrits dans la description peuvent être utilisés pour sélectionner un traitement d'un sujet susceptible d'être atteint de RPs.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2016170513A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
title RISK LOCUS FOR PSORIATIC ARTHRITIS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A45%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FERR%C3%81NDIZ%20FORASTER,%20Carlos&rft.date=2016-10-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2016170513A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true